Athira
Boats & Submarines · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Colemant Street #10-06 the Adelphi, Si...Phone Number
+62 7784803952Website
www.athiramarine.comRevenue
<$5 MillionIndustry
About Athira
Athira Org Chart
Is Athira your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Athira has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Athira has new funding data
Congratulate Masked Content for being promoted to Masked Content at Athira
Earning: See what the market has to say on Athira recently announced quarterly report
Athira, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Athira launches new products
Check out if Athira is spiking on competitors!
Click to see if Athira had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Athira as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Athira is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Athira is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Athira.
Athira Tech Stack
A closer look at the technologies used by Athira
Athira News & Media
Glancy Prongay & Murray LLP and Labaton Keller Sucharow LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Athira Pharma, Inc. - (NASDAQ: ATHA)
SEATTLE, June 10, 2024 /PRNewswire/ -- Nacif, et al. v. Athira Pharma, Inc., et al., Case No: 2:21-cv-00861-TSZ (W.D. Wash). SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT; (II) FINAL APPROVAL HEARING; AND (III) MOTION FOR AN AWARD OF ATTORNEYS' FEES AND PAYMENT OF...Athira Pharma's stock plummets after disappointing drug trial results
Stock of Bothell-based biotech Athira Pharma Inc. (Nasdaq: ATHA) tumbled more than 66% Wednesday after the company released disappointing clinical results for its drug aimed at treating Alzheimer's and Parkinson's dementia. The results indicated Athira's lead drug, ATH-1017, also called… - www.bizjournals.comAthira shareholder suspends push for board control days before shareholders' meeting
Athira shareholder Richard Kayne had sent multiple letters to shareholders in recent months slamming the biotech's leadership. - www.bizjournals.comInvestor who called for ouster of Athira Pharma CEO suspends campaign
The activist shareholder behind an attempt to replace the CEO of Athira Pharma has suspended his campaign. Billionaire Richard (Ric) Kayne nominated himself and an associate to the board in March, and recently proffered Ronald Krall, the chief medical officer of GlaxoSmithKline, as a replacement for current CEO Mark Litton. But on Tuesday Kayne pulled back in a letter to the board, days before the company’s annual shareholder meeting on Thursday. “It is clear it
Top Boats & Submarines Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Athira
PT ATHIRA LAUTAN SAMUDERA is a prominent shipbuilding and ship repair company located on Batam Island, strategically positioned in Southeast Asia. The company focuses on producing high-quality, domestically made ship components such as windlasses, winches, steering gears, and cranes, ensuring international quality standards. Their target clients in... Read More